Latest News on CDNA

Financial News Based On Company


Advertisement
Advertisement

Cathie Wood Pounces On Peter Thiel-Backed Bullish Stock After Wild IPO Surge: Ark Buys Stock Worth $172.22 Million - ARK Fintech Innovation ETF ( BATS:ARKF ) , ARK Innovation ETF ( BATS:ARKK )

https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/08/47111677/cathie-wood-pounces-on-peter-thiel-backed-bullish-stock-after-wild-ipo-surge-ark-buys-
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Bullish BLSH and Shopify Inc SHOP.

CareDx ( CDNA ) EPS Beats Sales Gain 14%

https://www.fool.com/data-news/2025/08/07/caredx-cdna-eps-beats-sales-gain-14/
CareDx ( NASDAQ:CDNA ) , a molecular diagnostics company specializing in transplant care solutions, released its results for the second quarter of fiscal 2025 on August 6, 2025. The big news from the release was a solid beat on non-GAAP earnings per share, reporting $0.10 against an expected ...

CareDx ( CDNA ) Lags Q2 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2675095/caredx-cdna-lags-q2-earnings-and-revenue-estimates
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CareDx ( CDNA ) Surges 7.0%: Is This an Indication of Further Gains?

https://www.zacks.com/stock/news/2602577/caredx-cdna-surges-70-is-this-an-indication-of-further-gains
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings - GameSquare Holdings ( NASDAQ:GAME ) , CareDx ( NASDAQ:CDNA )

https://www.benzinga.com/markets/market-summary/25/07/46469086/dow-jumps-over-100-points-pepsico-posts-upbeat-earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.32% to 44,398.39 while the NASDAQ rose 0.42% to 20,817.71. The S&P 500 also rose, gaining, 0.27% to 6,280.57.
Advertisement

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - CareDx ( NASDAQ:CDNA )

https://www.benzinga.com/pressreleases/25/05/g45556228/johnson-fistel-has-commenced-an-investigation-on-behalf-of-caredx-inc-shareholders
SAN DIEGO, May 21, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. CDNA for potential breaches of fiduciary duties and violations of the federal securities laws.

CareDx ( CDNA ) Tops Q1 Earnings Estimates

https://www.zacks.com/stock/news/2459529/caredx-cdna-tops-q1-earnings-estimates
CareDx (CDNA) delivered earnings and revenue surprises of 50% and 0.30%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Elevance Health ( ELV ) Soars 5.4%: Is Further Upside Left in the Stock?

https://www.zacks.com/stock/news/2440808/elevance-health-elv-soars-54-is-further-upside-left-in-the-stock
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Arhaus ( NASDAQ:ARHS )

https://www.benzinga.com/trading-ideas/movers/25/03/44559589/robinhood-couchbase-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
U.S. stock futures were lower this morning, with the Dow futures falling more than 250 points on Monday. Shares of Robinhood Markets, Inc. HOOD fell sharply in today's pre-market trading amid decline in Bitcoin BTC/USD prices. Bitcoin prices fell below the $82,000 mark this morning.

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - ARK Fintech Innovation ETF ( ARCA:ARKF ) , ARK Genomic Revolution ETF ( BATS:ARKG )

https://www.benzinga.com/25/03/44345451/cathie-woods-ark-invest-continues-to-offload-uipath-roblox-loads-up-on-gitlab-ibotta
On Friday, Mar. 14, 2025, the Cathie Wood-led Ark Invest made significant trades involving GitLab Inc GTLB, Intellia Therapeutics Inc NTLA, Prime Medicine Inc PRME, UiPath Inc PATH, Ibotta Inc IBTA, Roblox Corp RBLX, Repare Therapeutics Inc RPTX, and CareDx Inc CDNA.
Advertisement

Cathie Wood's Wednesday Moves: Ark Pours $1.36 Million Into Tempus AI Shares Following Deep 6 AI Acquisition, Offloads Rocket Lab Stock - ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ ) , ARK Innovation ETF ( ARCA:ARKK )

https://www.benzinga.com/25/03/44293571/cathie-woods-wednesday-moves-ark-pours-1-36-million-into-tempus-ai-shares-following-deep-6-ai-acquisition-offload
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM and Rocket Lab USA Inc. RKLB. Ark Invest's ARK Innovation ETF ARKK acquired 29,845 shares of Tempus AI, valued at approximately $1.36 million, based on the closing price of $45.50.

Here's Why Community Health's Florida Divestiture Matters

https://www.zacks.com/stock/news/2425398/heres-why-community-healths-florida-divestiture-matters
Offloading the Punta Gorda facility is expected to remove uncertainty tied to restoration costs and revenue losses for CYH.

New Strong Buy Stocks For February 27th - Barclays ( NYSE:BCS ) , CareDx ( NASDAQ:CDNA )

https://www.benzinga.com/markets/equities/25/02/44003596/new-strong-buy-stocks-for-february-27th
Here are five stocks added to the Zacks Rank #1 ( Strong Buy ) List today:

New Strong Buy Stocks for February 27th

https://www.zacks.com/commentary/2420915/new-strong-buy-stocks-for-february-27th
BCS, CDNA, PGR, EZPW and EVER have been added to the Zacks Rank #1 (Strong Buy) List on February 27, 2025.

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Agilon Health ( NYSE:AGL ) , Accel Entertainment ( NYSE:ACEL )

https://www.benzinga.com/25/02/43971065/flywire-posts-downbeat-results-joins-lemonade-ginkgo-bioworks-and-other-big-stocks-moving-lower-in-wednesdays-pre
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Wednesday. Shares of Flywire Corporation FLYW fell sharply in today's pre-market trading after the company reported worse-than-expected quarterly financial results.
Advertisement

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Acadian Asset Management ( NYSE:AAMI ) , Accel Entertainment ( NYSE:ACEL )

https://www.benzinga.com/25/02/43967093/why-zoominfo-technologies-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket
Shares of ZoomInfo Technologies Inc. ZI rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates.

Pediatrix Medical Group ( MD ) Surpasses Q4 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2418316/pediatrix-medical-group-md-surpasses-q4-earnings-and-revenue-estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of 37.84% and 3.44%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

CareDx ( CDNA ) Soars 11.2%: Is Further Upside Left in the Stock?

https://www.zacks.com/stock/news/2413272/caredx-cdna-soars-112-is-further-upside-left-in-the-stock
CareDx (CDNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Does CareDx ( CDNA ) Have the Potential to Rally 42.25% as Wall Street Analysts Expect?

https://www.zacks.com/stock/news/2410161/does-caredx-cdna-have-the-potential-to-rally-4225-as-wall-street-analysts-expect
The consensus price target hints at a 42.3% upside potential for CareDx (CDNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Best Momentum Stocks to Buy for January 30th

https://www.zacks.com/commentary/2406236/best-momentum-stocks-to-buy-for-january-30th
OBK, BBCP and CDNA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 30, 2024.
Advertisement

New Strong Buy Stocks for January 30th

https://www.zacks.com/commentary/2405172/new-strong-buy-stocks-for-january-30th
BBCP, SDVKY, OBK, CDNA and NVAX have been added to the Zacks Rank #1 (Strong Buy) List on January 30, 2024.

Is CareDx ( CDNA ) Outperforming Other Medical Stocks This Year?

https://www.zacks.com/stock/news/2405630/is-caredx-cdna-outperforming-other-medical-stocks-this-year
Here is how CareDx (CDNA) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Organ Transplant Diagnostics Market Size to Surpass USD 12.57 Billion by 2033 | Straits Research

https://www.benzinga.com/pressreleases/25/01/g43301093/organ-transplant-diagnostics-market-size-to-surpass-usd-12-57-billion-by-2033-straits-research
New York, United States, Jan. 29, 2025 ( GLOBE NEWSWIRE ) -- An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are clinical diagnostic methods that improve the efficacy of transplantation procedures.

Best Momentum Stocks to Buy for January 21st

https://www.zacks.com/commentary/2400207/best-momentum-stocks-to-buy-for-january-21st
CDNA, AVXL and ALNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 21, 2025.

New Strong Buy Stocks for January 21st

https://www.zacks.com/commentary/2399568/new-strong-buy-stocks-for-january-21st
CDNA, ALNY, ICL, AVXL and AA have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2025.
Advertisement

Strength Seen in CareDx ( CDNA ) : Can Its 6.1% Jump Turn into More Strength?

https://www.zacks.com/stock/news/2396244/strength-seen-in-caredx-cdna-can-its-61-jump-turn-into-more-strength
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 - ARK Genomic Revolution ETF ( BATS:ARKG ) , Adaptive Biotechnologies ( NASDAQ:ADPT )

https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearl
On Monday, Cathie Wood-led Ark Invest made significant trades in five major companies: Palantir Technologies Inc. PLTR, Tempus AI Inc. TEM, CareDx Inc. CDNA, Veracyte Inc. VCYT, Adaptive Biotechnologies Corp. ADPT. Ark Invest's Ark Innovation ETF ARKK fund sold 140,518 shares of Palantir.

Implied Volatility Surging for CareDx ( CDNA ) Stock Options

https://www.zacks.com/stock/news/2392236/implied-volatility-surging-for-caredx-cdna-stock-options
Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.

Here's Why You Should Add Ensign Group Stock to Your Portfolio Now

https://www.zacks.com/stock/news/2388474/heres-why-you-should-add-ensign-group-stock-to-your-portfolio-now
ENSG should benefit from expanding facilities and growing footprint, leading to higher service revenues in the future.

Ensign Expands Footprint With Buyout of Eight Healthcare Facilities

https://www.zacks.com/stock/news/2387090/ensign-expands-footprint-with-buyout-of-eight-healthcare-facilities
ENSG agrees to buy eight healthcare facilities from Providence Home and Community Care, expanding its footprint.
Advertisement

Molina Healthcare Expands Dual Eligible Services in Michigan, Idaho

https://www.zacks.com/stock/news/2384408/molina-healthcare-expands-dual-eligible-services-in-michigan-idaho
MOH secures key contracts in Michigan and Idaho to expand services for dual-eligible populations, driving growth and strengthening its role in integrated care solutions.

Ensign Group Rewards Shareholders With 4.2% Dividend Hike

https://www.zacks.com/stock/news/2384117/ensign-group-rewards-shareholders-with-42-dividend-hike
ENSG hikes quarterly dividend by 4.2%, maintaining its record of raising dividends for the past 22 years.

Centene Unveils Its 2025 Guidance, Reaffirms 2024 Outlook

https://www.zacks.com/stock/news/2383447/centene-unveils-its-2025-guidance-reaffirms-2024-outlook
CNC expects robust growth in its Medicaid, Marketplace and Medicare businesses. This is likely to be driven by rate increases, rising uninsured individuals and dual expansions.

Community Health to Divest North Carolina Hospital for $280M

https://www.zacks.com/stock/news/2383025/community-health-to-divest-north-carolina-hospital-for-280m
CYH is selling the 123-bed facility in Mooresville to Duke Health.

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - TC BioPharm ( Holdings ) ( NASDAQ:TCBP ) , CareDx ( NASDAQ:CDNA )

https://www.benzinga.com/pressreleases/24/12/n42433153/tcbp-partners-with-caredx-to-support-achieve-clinical-trial-using-allocell-for-pharmacokinetic-mon
EDINBURGH, Scotland, Dec. 11, 2024 /PRNewswire/ -- TC BioPharm ( Holdings ) PLC ( "TC BioPharm" or the "Company" ) TCBP a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced a partnership with CareDx, ...
Advertisement

Brookdale's 37-Month Growth Streak: Is BKD Stock a Safe Bet?

https://www.zacks.com/stock/news/2381783/brookdales-37-month-growth-streak-is-bkd-stock-a-safe-bet
BKD's weighted average occupancy for November grows 10 bps sequentially.

Community Health Unit Northwest Urgent Closes Arizona Buyouts

https://www.zacks.com/stock/news/2378299/community-health-unit-northwest-urgent-closes-arizona-buyouts
CYH's acquisition expands Northwest Healthcare arm's network to more than 80 care sites.

Has CareDx ( CDNA ) Outpaced Other Medical Stocks This Year?

https://www.zacks.com/stock/news/2378239/has-caredx-cdna-outpaced-other-medical-stocks-this-year
Here is how CareDx (CDNA) and Clover Health Investments, Corp. (CLOV) have performed compared to their sector so far this year.

Cathie Wood Sees $400B Opportunity In Biologics - How Have Her Bets Fared? - ARK Genomic Revolution ETF ( BATS:ARKG ) , Adaptive Biotechnologies ( NASDAQ:ADPT )

https://www.benzinga.com/general/biotech/24/11/42206182/cathie-wood-sees-400b-opportunity-in-biologics-how-have-her-bets-fared
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.

Select Medical Distributes Concentra Shares to Shareholders

https://www.zacks.com/stock/news/2375155/select-medical-distributes-concentra-shares-to-shareholders
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
Advertisement

Wall Street Analysts Predict a 49.89% Upside in CareDx ( CDNA ) : Here's What You Should Know

https://www.zacks.com/stock/news/2374773/wall-street-analysts-predict-a-4989-upside-in-caredx-cdna-heres-what-you-should-know
The consensus price target hints at a 49.9% upside potential for CareDx (CDNA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Tenet Healthcare Partners With Commure for Ambient AI Platform

https://www.zacks.com/stock/news/2372873/tenet-healthcare-partners-with-commure-for-ambient-ai-platform
THC actively invests in selected AI-enabled technologies, which are expected to enhance the clinical and administrative workflow and efficiency.

After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx ( CDNA )

https://www.zacks.com/stock/news/2370976/after-plunging--1197-in-4-weeks-heres-why-the-trend-might-reverse-for-caredx-cdna
The heavy selling pressure might have exhausted for CareDx (CDNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Are Medical Stocks Lagging CareDx ( CDNA ) This Year?

https://www.zacks.com/stock/news/2370377/are-medical-stocks-lagging-caredx-cdna-this-year
Here is how CareDx (CDNA) and Doximity (DOCS) have performed compared to their sector so far this year.

DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal

https://www.zacks.com/stock/news/2369797/doj-lawsuit-questions-unitedhealths-33-billion-amedisys-deal
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
Advertisement

Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips

https://www.zacks.com/stock/news/2368678/cigna-ends-humana-merger-speculation-ci-jumps-73-while-hum-slips
CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.

Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat

https://www.zacks.com/stock/news/2366661/pediatrix-medical-stock-soars-305-since-q3-earnings-beat
MD expects transformational and restructuring-related expenses to be $48 million in 2024.

Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit

https://www.zacks.com/stock/news/2364526/teladoc-health-q3-loss-narrows-on-strong-integrated-care-unit
TDOC expects 2024 U.S. Integrated Care Members to remain within 93.5-94.5 million.

Humana Q3 Earnings Beat on Growing Premiums & Cost Management

https://www.zacks.com/stock/news/2360956/humana-q3-earnings-beat-on-growing-premiums-cost-management
Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.

Cathie Wood's Sky-High Vision: Dumps Shares Of Cybercab Touting Tesla For This eVTOL Play - Archer Aviation ( NYSE:ACHR ) , ARK Innovation ETF ( ARCA:ARKK )

https://www.benzinga.com/markets/equities/24/10/41615718/cathie-woods-sky-high-vision-dumps-shares-of-cybercab-touting-tesla-for-this-evtol-play
On Tuesday, Cathie Wood's Ark Invest made some significant trades, most notably selling shares of Tesla Inc TSLA and buying a substantial amount of Archer Aviation Inc ACHR.
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion